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Abstract
Aims Diabetes guidelines recommend screening for the risk of foot ulceration but vary substantially in the underlying
evidence base. Our purpose was to derive and validate a prognostic model of independent risk factors for foot ulceration
in diabetes using all available individual patient data from cohort studies conducted worldwide.
Methods We conducted a systematic review and meta-analysis of individual patient data from 10 cohort studies of risk
factors in the prediction of foot ulceration in diabetes. Predictors were selected for plausibility, availability and low
heterogeneity. Logistic regression produced adjusted odds ratios (ORs) for foot ulceration by ulceration history,
monofilament insensitivity, any absent pedal pulse, age, sex and diabetes duration.
Results The 10 studies contained data from 16 385 participants. A history of foot ulceration produced the largest OR
[6.59 (95% CI 2.49 to 17.45)], insensitivity to a 10 g monofilament [3.18 (95% CI 2.65 to 3.82)] and any absent pedal
pulse [1.97 (95% CI 1.62 to 2.39)] were consistently, independently predictive. Combining three predictors produced
sensitivities between 90.0% (95% CI 69.9% to 97.2%) and 95.3% (95% CI 84.5% to 98.7%); the corresponding
specificities were between 12.1% (95% CI 8.2% to 17.3%) and 63.9% (95% CI 61.1% to 66.6%).
Conclusions This prognostic model of only three risk factors, a history of foot ulceration, an inability to feel a 10 g
monofilament and the absence of any pedal pulse, compares favourably with more complex approaches to foot risk
assessment recommended in clinical diabetes guidelines.
Diabet. Med. 35, 1480–1493 (2018)
Background
Diabetes-related lower extremity amputations and foot ulcers
cause considerable morbidity, more than double the rate of
mortality and generate a high monetary cost for health and
social care systems [1,2]. The high prevalence of diabetes and
increasing incidence in many developing countries mean this
complication is likely to become more burdensome.
Across the globe, clinical guidelines for diabetes recom-
mend screening for the risk of foot ulceration but individual
guidelines vary substantially in the evidence used to support
recommendations with many based on clinical consensus [3–
8]. The consequence of this situation is a wide variation in
the clinical symptoms, signs and tests that health profession-
als use to identify a person’s risk of foot ulceration.
Moreover, because foot risk assessment tools are often
derived in people at high risk of ulceration [9,10], they may
not perform well in people whose risk is low. Because some
of the recommended tools require expensive equipment and
clinically time-consuming procedures there is likely to be
considerable value in the identification of a simple, evidence-
based, risk assessment tool with high prognostic value.
Our purpose was to derive and validate a prognostic model
of independent risk factors for foot ulceration in diabetes
using all available individual patient data (IPD) from cohort
studies conducted worldwide to inform the development of
an evidence-based clinical prediction rule [11,12].
Correspondence to: Fay Crawford. E-mail: fay.crawford@nhs.net
This article is published with the permission of the Controller of HMSO and
the Queen’s Printer for Scotland.
Methods
We undertook a systematic review and meta-analyses of IPD
collected in cohort studiesofpredictive factors for footulceration
in diabetes (PROSPERO no: CRD42011001841). Ethical
approval was not required because the data were anonymized,
already published and in the public domain [13,14].
Included studies had to recruit people with a diagnosis of
diabeteswhowere freeof footulceration,orwhoseauthorscould
provide separate data from those who did not have ulceration at
recruitment. The outcome of interest was foot ulceration.
The review eligibility criteria
People aged 18 years old and over, with a diagnosis of
diabetes (Type 1 or Type 2), with at least one foot, who were
free of ulceration at the time of entry to a cohort study with
ulceration as the outcome variable.
Search strategies
Electronic searches were conducted in MEDLINE and
Embase databases from inception to August 2017 (MED-
LINE) and June 2017 (Embase). One reviewer applied the
review eligibility criteria to the full-text articles and a second
reviewer checked a 10% random sample to ensure that no
eligible studies were missed [14].
Quality assessment
We compiled a list of items relevant to our review question
sourced from published quality assessment checklists for
cohort studies[15,16].
Development of the model
Data were cleaned, and extreme values checked with the
authors. Where there were missing data, discussions to
understand the pattern of missingness took place. We
included variables for which the greatest amount of data
from several sources were available. Variables had to have
been collected in at least three data sets; be defined
consistently across data sets (or be able to be recoded) and
the extent of heterogeneity should not be so large as to
invalidate the meta-analysis.
A univariate logistic regression analysis was performed
to obtain odds ratios (ORs) using all variables which met
our criteria. The ORs were examined in forest plots to
assess heterogeneity, then those variables thought to be
clinically important, biologically plausible, and easy to
measure in clinical practice were considered by the whole
research team.
For data from a particular study to be included in the
model it must have a complete set of these variables. There
was a trade-off between the number of variables and the
number of studies that were included, with more variables
leading to fewer studies because of lack of additional
variables in study data sets.
Primary statistical analysis
A multivariable model was fitted using the core variables of
the primary model in each separate cohort study using
logistic regression with first incident foot ulceration as the
binary outcome. We did not analyse predictors of recurrent
ulceration. We adjusted the ORs from each study with the
same set of predictors [17–19]. These were included in meta-
analyses using a random effects model by the generic inverse
method and heterogeneity was assessed using I2 and tau-
statistics [20]. We conducted the analyses first using patient
data from the total population regardless of previous history
of foot ulceration and a second analysis using only data from
people with no previous history of foot ulceration to check
whether the same variables were predictive in both groups.
Our approach to a planned survival analysis deviated from
our published protocol in that we performed a two-step
meta-analyses because the largest cohort study (n = 6603)
[21] had no time-to-ulceration data and another large data
set (n = 3412) [22] was only available to the project
statisticians via a Safe Haven facility and could not be
physically merged with the other data sets for a one-step
approach [23].
To validate the final model an independent statistician re-
estimated the ORs in a new data set (n =1489) not previously
used in our analysis, to allow a comparison of the ORs from
our meta-analysis [24].
We calculated sensitivity, specificity and positive and
negative likelihood ratios for an inability to feel a 10 g
monofilament and/or any absent pedal pulse with ulceration
What’s new?
• Cohort studies to identify risk factors for foot ulcera-
tion in people with diabetes have been published in the
biomedical literature since the early 1990s.
• We assembled an international data set of risk factors
collected from 16 385 individuals with diabetes who
took part in cohort studies to derive and validate a
prognostic model of three risk factors: a history of foot
ulceration, an inability to feel a 10 g monofilament and
at least one absent pedal pulse.
• The use of only these three risk factors in foot risk
assessments during annual diabetes foot checks could
reduce the amount of time spent assessing risk and
thereby increase the number of people with diabetes
who have checks performed.
• The frequency of risk assessment should be considered
in future research.
at 1 and 2 years after the risk assessments took place as these
tests survived validation. Finally, we calculated these same
measures of diagnostic accuracy for the three risk factors that
survived validation (the above and history of foot ulceration)
for foot ulceration at 1 and 2 years. Heterogeneity was
assessed visually with forest plots but not with I2 or tau-
statistics because these are less reliable with small numbers of
studies. Logistic regression and meta-analyses were con-
ducted with SAS 9.3 and the meta package in R. Analyses of
sensitivity and specificity were all conducted using the
DiagMeta package in R (https://cran.r-project.org/).
Results
We contacted the principal investigators of 17 studies [22–
38] that met the eligibility criteria and an agreement to share
anonymized data was obtained from 10 [22–24,32–38]. The
flow of studies throughout the review and the reasons for
exclusion can be found in Fig. S1.
Data from 16 385 people with diabetes were obtained, of
these 1221 (7.5%) experienced a foot ulcer (Fig. S2). Authors
of eight studies made ‘raw’ data available [22,32–38] and
data from a ninth study were made available via Safe Haven,
a data management system with secure and restricted access
[23]. Finally, a tenth corresponding author was not granted
permission from his Institutional Review Board to share data
[24] but was able to contribute to the meta-analysis by
subjecting the data from his cohort study to the same
analytical procedures as all other studies in our meta-analysis
to provide estimates of ORs that externally validated the
final model independently. The characteristics of each
individual study can be found in Table 1.
The percentage of missing data in the studies included in
the final model was < 3% (range 0–2.9%). Eye problems,
tuning fork, ankle reflexes, foot deformity, ethnicity, living
alone, pin-prick test, temperature test and peak plantar
pressure variables were either not collected in a minimum of
three studies or were inconsistently measured across studies
and it was not possible to standardize them. We chose any
absent pedal pulse rather than ankle–brachial indices as a
measure of peripheral vascular disease because more studies
collected these data. The variables selected for inclusion in
the primary model by our international multidisciplinary
team were: age, sex, duration of diabetes, prior ulceration or
amputation, any absent dorsalis pedis or posterior tibialis
pulse on either foot, and insensitivity to 10 g monofilament
at any foot site.
The primary meta-analysis
The results of the univariate and primary multivariable
model meta-analyses together with those from the validation
analysis are presented in Tables 2 and 3. Forest plots of the
pooled ORs with 95% confidence intervals (CIs) are
provided for the primary model’s predictors in multivariable
analyses in Figs 1–3 and S3–S5. The ORs in the multivariable
analyses were adjusted for age, sex, duration of diabetes,
insensitivity to 10 g monofilament, any absent pedal pulse,
and history of foot ulceration.
A history of foot ulceration was found to be predictive of
diabetes-related foot ulceration. This effect was also
observed in the analyses of the external data set (Fig. 1)
(meta-analyses OR 6.59, 95% CI 2.49 to 17.45; validation
OR 2.98, 95% CI 2.15 to 4.13).
The 10 g monofilament test was shown to be consistently
predictive in the meta-analyses and in the external validation
data set (Fig. 2) (meta-analyses OR 3.18, 95% CI 2.65 to
3.82; validation OR 3.49, 95% CI 2.49 to 4.89). Notably the
estimated heterogeneity was zero.
The absence of at least one pedal pulse was shown to be
predictive in the meta-analyses and the validation data set
(Fig. 3) (meta-analyses OR 1.97, 95% CI 1.62 to 2.39;
validation OR 2.56, 95% CI 1.22 to 5.36).
The duration of diabetes was not found to be consistently
predictive between the meta-analyses of nine studies (Fig. S3)
(meta-analyses OR 1.02, 95% 1.01 to 1.04) when compared
with the analysis of the validation data set (OR 0.98, 95 CI
0.97 to 0.99).
Age was not found to be predictive of foot ulceration in
either the meta-analyses (Fig. S4) or the external validation
data set (meta-analyses OR 1.00, 95% CI 0.99 to 1.02;
validation OR 0.99, 95% CI 0.98 to 1.01).
Female sex was found to be protective of foot ulceration
across studies in the IPD meta-analysis (meta-analyses OR
0.74, 95% CI 0.60 to 0.92) (Fig. S5) but this finding was not
replicated in the validation study, which includedmostly men.
The ORs calculated from meta-analyses of data from
people who had never experienced a foot ulcer did not differ
statistically from the analysis of data from the entire study
population data except for the variable ‘female sex’
(Table 3). The results for gender were not statistically
significantly different for people who had no history of
ulceration (OR 0.84, 95% CI 0.68 to 1.04) but were
statistically significantly different in the total population (OR
0.74 (95% CI 0.60 to 0.92), the latter estimate suggesting
female gender is protective of foot ulceration in those who
have a history of foot ulceration.
The calculation of accuracymeasureswithin 1 and2 years of
assessment using the two risk factors in combination was only
possible in three studies because these had ulcers necessary for
analyses at 1 and 2 years (n = 1781) [32,33,36]. The estimates
of sensitivity, specificity and likelihood ratios for a 10 g
monofilament test used alone, the absence of any pedal pulse
used alone and the combined use of a 10 g monofilament test
and any absent pedal pulse results where one or other of these
elements produces a positive result are presented in Table 4.
Heterogeneity in the pooled specificity data makes meta-
analyses of these data impractical (Figs S6 and S7) hence we
report the sensitivities, specificities and likelihood ratios of the
three studies individually.
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The results from either the 10 g monofilament test or any
absent pedal pulse being positive were found to increase the
sensitivities in each study, ranging from 74.2% to 95.3% at a
cost to the specificities (specificities ranging from 27.1% to
66.3%), the corresponding positive likelihood ratio varied
from 1.31 to 2.31 and the negative likelihood ratio from 0.17
to 0.54. (Table 4, Fig. S8).
For each study, no statistically significant differences were
found between 1 and 2 years for the majority of measures
using the monofilament test or any absent pedal pulse alone
or combined. (Table 4).
Estimates of sensitivity and specificity from combining
all three risk factors increased the sensitivity and reduced
the specificity of the prognostic model at 1 and 2 years
after testing (n = 1781). The sensitivity and specificity for
a 10 g monofilament test, the absence of any pedal pulse
and a history of foot ulceration (where any one of the
elements produces a positive result) are presented in
Table 5.
Risk assessments with all three risk factors at an interval of
1 year show sensitivities of between 90.0% and 95.3%,
while the corresponding specificities were reduced to
Table 2 Pooled estimates of association between the predictors and foot ulceration in the univariate (unadjusted) analysis
New ulcer predictor N Odds ratio (95% confidence interval) I2 (%); tau (level of heterogeneity)
Age 14 823 1.02 (1.01 to 1.03) 26.7; 0
Sex (women v men) 14 895 0.59 (0.47 to 0.74) 46.8; 0.44
Weight 1965 1.01 (0.996 to 1.02) 16.1; 0
Height 2030 1.05 (1.03 to 1.06) 0; 0
BMI 6662 0.98 (0.97 to 1.00) 0; 0
Smoking (yes/no) 12 522 0.96 (0.83 to 1.12) 0; 0
No. of cigarettes per day 6222 1.02 (0.99 to 1.05) 60.9; 0.001
Alcohol (yes/no) 8193 0.92 (0.59 to 1.43) 38.8; 0.08
Alcohol units per week 3786 1.01 (1.00 to 1.02) 0; 0
HbA1c (mmol/mol (%)) 7119 1.20 (1.10 to 1.30) 50; 0
Insulin treatment 10 869 1.75 (1.17 to 2.62) 71.5; 0.16
Diabetes duration 14 199 1.05 (1.03 to 1.07) 81.7; 0
Eye problem (yes/no) 8099 2.49 (1.99 to 3.15) 0; 0
Retinopathy 2724 2.09 (.55 to 2.82) 0; 0
Kidney problems 12 438 1.83 (1.18 to 2.83) 60.5; 0
Inability to feel 10g monofilament 12 030 5.61 (4.47 to 7.04) 37.1; 0.027
Any absent pedal pulse 12 327 3.47 (2.32 to 5.21) 80; 0.181
Abnormal vibration perception threshold (VPT) 10 336 7.61 (3.82 to 15.16) 82.5; 0.516
Absent ankle reflex 7879 2.10 (0.71 to 6.22) 89.1; 0.808
Abnormal ankle–brachial index (ABI) 1868 1.836 (0.99 to 3.41) 30.4; 0.124
Any foot deformity 12 093 3.171 (2.16 to 4.65) 57.2; 0.114
History of foot ulceration 14 656 13.74 (6.60 to 28.58) 93.7; 1.022
Previous amputation 11 762 10.31 (4.93 to 21.56) 76.5; 0.469
History of foot ulceration or lower limb amputation 14 709 13.18 (6.56 to 26.51) 93.4; 0.923
Table 3 Comparison of results between the primary multivariable model meta-analysis and the external validation data set
Predictor Source Odds ratio 95% CI
History of foot ulceration Meta-analysis of all data 6.59 2.49 to 17.5
Boyko validation data set 2.98 2.15 to 4.14
Inability to feel a 10 g monofilament Meta-analysis of all data 3.18 2.65 to 3.82
Meta-analysis of data from pts with no history 3.44 2.77 to 4.26
Boyko validation data set 3.49 2.49 to 4.90
Any absent pedal pulse Meta-analysis of all data 1.97 1.62 to 2.39
Meta-analysis of data from pts with no history 2.61 1.81 to 3.75
Boyko validation data set 2.56 1.22 to 5.36
Sex (female) Meta-analysis of all data 0.74 0.60 to 0.92
Meta-analysis of data from pts with no history 0.84 0.68 to 1.04
Boyko validation data set 1.49 0.42 to 5.32
Duration of diabetes Meta-analysis of all data 1.02 1.01 to 1.04
Meta-analysis of data from pts with no history 1.03 1.02 to 1.04
Boyko validation data set 0.98 0.97 to 0.99
Age Meta-analysis of all data 1.00 0.99 to 1.02
Meta-analysis of data from pts with no history 1.01 0.995 to 1.02
Boyko validation data set 0.99 0.98 to 1.01
between 12.1% and 63.8%. Risk assessments at 2-year
intervals with the three risk factors in combination showed
sensitivities between 90.9% and 95.6% with corresponding
specificities reduced to between 13.2% and 63.9% (Table 5).
Any absent pulse was found to be more informative than the
three-factor model in the population reported by Pham [36].
In one study [33], the three-factor model sensitivity
exceeded that of the two-factor model by a statistically
significant degree at 2 years (Tables 4 and 5). In another
study [36], the three-factor model specificity was statistically
significantly lower than that of the two-factor model at both
1 and 2 years (Tables 4 and 5).
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FIGURE 1 Pooled adjusted estimates for previous history or lower extremity amputation (LEA). (Model adjusted for age, sex, duration of diabetes,
inability to feel a 10g monofilament and absent pedal any absent pedal pulse) The odds ratio indicates a previous history of foot ulceration or LEA is
predictive of diabetes-related foot ulceration.
Risk of bias
For the five items used to assess the quality of the conduct of the
studies, five studies exhibited a low risk of bias [22,32,33,36,38]
(Table 6). However, the collection of outcomes in a ‘blind’
manner was a feature of only 50% the studies which exposes
some of these data to the threat of investigator bias.
Discussion
The central importance of foot risk assessment in health
checks for people with diabetes is acknowledged by health-
care systems across the world. Our analyses, based on data
collected internationally, indicate that only three risk factors,
a history of foot ulceration, the inability to feel a 10 g
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FIGURE 2 Pooled adjusted estimates for the inability to feel a 10g monofilament. (Model adjusted for age, sex, duration of diabetes, absent pedal any
absent pedal pulse and previous history of foot ulceration or amputation) The odds ratio indicates an inability to feel a 10g monofilament is
predictive of diabetes-related foot ulceration.
monofilament and the absence of at least one pedal pulse, are
required to distinguish between those who will ulcerate and
those who will not with a high degree of accuracy compa-
rable with other, more complex, prognostic models [39]. The
simplicity of our model has advantages for clinical practice
because it is intuitively correct to suppose that the fewer tests
and elements from the patient history that healthcare
professionals are required to consider, the more likely risk
assessment procedures will be performed.
The very large ORs calculated for a history of foot
ulceration were perhaps unsurprising and there can be no
doubt about the high-risk status of these individuals.
However, the most consistent set of results in the meta-
analysis were obtained from data for the 10 g monofilament
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FIGURE 3 Pooled adjusted estimates for any absent pedal pulse. (Model adjusted for age, sex, duration of diabetes, inability to feel a 10g
monofilament and previous history of foot ulceration or amputation) The odds ratio indicates the absence of a pedal pulse is predictive of diabetes-
related foot ulceration.
test and this quick, simple and relatively cheap test identified
risk in all cohort studies with remarkable consistency. The
almost complete absence of heterogeneity in the meta-
analyses of monofilament data came from five studies
involving 11 522 people from three different countries, and
as such was unexpected.
The results for any absent pedal pulse indicate that this
sign is also independently predictive of a risk of foot
ulceration. Our use of ‘any absent pedal pulse’ as a measure
of peripheral vascular disease may have underestimated the
predictive value of vascular disease for foot ulceration. In a
study of major vascular outcomes in people with Type 2
diabetes, every additional absent pedal pulse resulted in a
proportional increase in the hazard ratios [40].
Adding the palpation of any absent pedal pulse to an
inability to feel a 10 g monofilament increases sensitivity at
1- and 2-year intervals. When two and three factors were
combined, higher levels of sensitivity, but correspondingly
lower levels of specificity, were observed. This is because any
two tests combined with a Boolean OR are bound to increase
sensitivity at the expense of specificity. Whether this is
acceptable depends on the clinical context [41] but in this
scenario the consequences of failing to detect a person at risk
of foot ulceration (false negatives) may be potentially far
more serious than the increased routine healthcare costs
associated with false-positive results from a test with lower
specificity. The high levels of sensitivity for the combined
models support the extension of screening intervals beyond
Table 4 Estimates of sensitivity, specificity and likelihood ratios at 1 and 2 years for the inability to feel a 10 g monofilament alone, at least one
absent pedal pulse alone and inability to feel a 10 g monofilament OR at least one absent pedal pulse based on three cohort studies with time-to-
event data (n = 1781). Participant is test positive if any of the risk factors is positive, and negative otherwise
Study Test
Timepoint
(year)
% Sensitivity
(95% CI)
% Specificity
(95% CI)
Positive
likelihood
ratio
Negative
likelihood
ratio
Crawford Monofilament OR Any
absent pedal pulse
1 77.8 (54.8, 91.0) 66.3 (63.6, 69.0) 2.31 (1.78, 3.00) 0.34 (0.14, 0.80)
Monofilament OR Any
absent pedal pulse
2 81.8 (61.5, 92.7) 66.6 (63.8, 69.2) 2.45 (1.98, 3.03) 0.27 (0.11, 0.66)
Monofilament 1 50.0 (29.0, 71.0) 77.9 (75.4, 80.2) 2.26 (1.41, 3.63) 0.64 (0.40, 1.02)
Monofilament 2 59.1 (0.39, 0.77) 78.1 (75.7, 80.4) 2.70 (1.88, 3.89) 0.52 (0.32, 0.87)
Any absent pedal pulse 1 66.7 (43.7, 83.7) 81.9 (79.6, 84.0) 3.69 (2.60, 5.22) 0.41 (0.21, 0.78)
Any absent pedal pulse 2 59.1 (38.7, 76.7) 81.9 (79.6, 84.0) 3.27 (2.26, 4.73) 0.50 (0.30, 0.83)
Monteiro Monofilament OR Any
absent pedal pulse
1 74.2 (56.8, 86.3) 47.7 (42.4, 53.1) 1.42 (1.13, 1.79) 0.54 (0.30, 0.99)
Monofilament OR Any
absent pedal pulse
2 70.6 (57.0, 81.3) 48.5 (43.0, 54.1) 1.37 (1.12, 1.69) 0.61 (0.39, 0.94)
Monofilament 1 54.8 (37.8, 70.8) 54.7 (49.3, 60.0) 1.21 (0.86, 1.70) 0.83 (0.55, 1.23)
Monofilament 2 54.9 (41.4, 67.7) 55.3 (49.8, 60.8) 1.23 (0.93, 1.62) 0.82 (0.59, 1.12)
Any absent pedal pulse 1 38.7 (23.7, 56.2) 81.5 (76.9, 85.3) 2.09 (1.27, 3.43) 0.75 (0.57, 1.00)
Any absent pedal pulse 2 31.4 (20.3, 45.0) 81.6 (76.9, 85.5) 1.70 (1.06, 2.72) 0.84 (0.69, 1.02)
Pham Monofilament OR Any
absent pedal pulse
1 95.3 (84.5, 98.7) 27.1 (21.4, 33.7) 1.31 (1.18, 1.46) 0.17 (0.04, 0.68)
Monofilament OR Any
absent pedal pulse
2 89.7 (80.2, 94.9) 28.2 (22.0, 35.3) 1.25 (1.10, 1.41) 0.37 (0.17, 0.77)
Monofilament 1 95.3 (84.5, 98.7) 28.6 (22.8, 35.3) 1.34 (1.20, 1.49) 0.16 (0.04, 0.64)
Monofilament 2 89.7 (80.2, 94.9) 29.9 (23.6, 37.1) 1.28 (1.13, 1.45) 0.34 (0.17, 0.72)
Any absent pedal pulse 1 27.9 (16.7, 42.7) 88.4 (83.3, 92.2) 2.42 (1.31, 4.47) 0.84 (0.67, 0.99)
Any absent pedal pulse 2 25.0 (16.2, 36.4) 89.7 (84.2, 93.4) 2.42 (1.33, 4.41) 0.84 (0.72, 0.97)
Table 5 Estimates of sensitivity and specificity for the inability to feel a 10 g monofilament, at least one absent pedal pulse alone and a history of
foot ulceration combined at 1- and 2-year follow-ups based on three cohort studies with time-to-event data. Patient is test positive if any of the risk
factors is positive, and negative otherwise. Meta-analysis not performed because of high levels of heterogeneity in the estimates of specificity
Study Test
Time
point
% Sensitivity
(95% CI)
% Specificity
(95% CI)
Positive likelihood
ratios (95% CI)
Negative Likelihood
ratios (95% CI)
Crawford (2011) Three predictors 1 90.0 (69.9, 97.2) 63.8 (61.0, 66.5) 2.48 (2.11, 2.93) 0.16 (0.04, 0.58)
Three predictors 2 90.9 (72.2, 97.5) 63.9 (61.1, 66.6) 2.52 (2.16, 2.93) 0.14 (0.04, 0.53)
Monteiro-Soares (2010) Three predictors 1 94.1 (80.9, 98.4) 39.6 (34.4, 45.0) 1.56 (1.38, 1.76) 0.15 (0.04, 0.57)
Three predictors 2 94.2 (84.4, 98.0) 41.6 (36.2, 47.1) 1.61 (1.44, 1.81) 0.14 (0.05, 0.42)
Pham (2000) Three predictors 1 95.3 (84.5, 98.7) 12.1 (8.2, 17.3) 1.08 (0.997, 1.18) 0.39 (0.10, 1.57)
Three predictors 2 95.6 (87.8, 98.5) 13.2 (09.0, 19.1) 1.10 (1.02, 1.19) 0.33 (0.10, 1.08)
the conventional 1 year in those who test negative (i.e. do not
exhibit either two or three risk factors).
The variation in the accuracy of the two- and three-factor
models in the two smaller studies deserves consideration. The
heterogeneity in the effects of predictive models can arise
from differences in disease spectrum, populations, settings,
timing and the prevalence of the disease or outcome
(incidence) [42,43]. The ulcer incidence was higher in two
studies [33,36], as was the number of re-ulcerations, com-
pared with the population described by Crawford (Table 1)
[32]. The worse foot pathology of these people may also
explain the likelihood ratios obtained for these two cohorts
which indicate that the informative value of the models is
low [44].
The number of years that a person has had a diagnosis of
diabetes was found to be a risk factor, but there is a high
level of heterogeneity in the meta-analyses and this finding
was not confirmed in the validation analysis. Female sex
seems to confer some protection against ulceration and this
might relate to a greater propensity for self-care and
attention to foot health among the women in the study
populations [45], or reflect other physiological or beha-
vioural differences relating to sex. Sex was not validated as a
significant predictor in the validation data set, which had a
predominantly male population [24].
The quality of the conduct of the 10 studies included in the
systematic review was assessed as high. Only one item was
found to threaten the validity of the included studies: the
blinding of the individuals who ascertained the outcome
variable (ulceration) was only maintained in 50% of the
included studies [22,32,33,36,38]. This is widely believed to
be an important quality factor in prognostic studies and
clinical prediction rules [46,47]. However, the meta-analyses
upon which our conclusions are based included only one
study [23] in which the investigators knew the status of the
index test results for some cases and the estimates these data
contribute only differ statistically from pooled estimates for
one prognostic factor – previous history of ulceration or
amputation. This may result from the inherent difference in
study design, being the only study to use routinely collected
data.
Strength and limitations of the results
Our externally validated prognostic model for foot ulcera-
tion in diabetes used all obtainable IPD from global cohort
studies and the analysis is based on data from 11 816 people
with diabetes, the largest of its kind. The differences in the
demographics of the included populations, the international
and clinical settings in which the data were collected and the
variety of health care professionals who undertook the foot
assessments mean the findings have good external validity.
That our international, multidisciplinary group of individu-
als considered the most clinically useful variables for
inclusion in a prognostic model helped ensure that all clinical
perspectives and expertise were represented.
The main limitation of the work is that the model results
are expressed as summary ORs, which do not readily allow
clinicians to assess risk and our research is on-going to
produce a clinical prediction rule with a simple scoring
system based on calculated relative risks from a sample of
these data. From these we plan to produce risk categories and
assess the performance of the clinical prediction rule by
analysing its properties of discrimination and calibration
[48]. The lack of data for systemic conditions such as stroke
or coronary heart disease is also a limitation; all three risk
factors in our model are intrinsic to the foot and none are
suitable for self-care. Furthermore, the small number of
studies (n = 3) included in the analysis of accuracy measures
of the model means these estimates of diagnostic accuracy
should be interpreted with caution.
Implications for policy, practice and research
Given the increased worldwide prevalence in diabetes, a
clinical prediction rule based on data collected globally and
Table 6 Risk of bias within the included studies.
Were a consecutive
sample of people
recruited?
Was the timing
of the follow-up
long enough for
an ulcer to develop?
Can the test be
replicated from
the description in
the published report?
Were the
investigators
who collected
the outcomes blind
to the results of the
index tests?
Has the study
size been fully justified?
Abbott (2002) Y Y Y Y N
Boyko (2006) Y Y Y N Y
Crawford (2011) Y Y Y Y Y
Kastenbauer (2001) Y Y Y N N
Leese (2011) Y Y Y N N
Monami (2009) Y Y Y N N
Monterio-Soares (2010) Y Y Y Y N
Pham (2000) Y Y Y Y N
Rith-Najarian (1992) N Y Y N N
Young (1994) Y Y Y Y N
involving only three risk factors that are easy to measure
could lead to more people with diabetes having foot ulcer
risk assessments and improved outcomes. The duration of
the screening interval should be the focus of future research
for this simplified prognostic model.
Conclusions
This systematic review and meta-analysis of IPD collected
worldwide has produced a simple prognostic model of three
risk factors that are independently predictive of foot risk
ulceration in diabetes. Although an even simpler model
appeared more suitable for use in a speciality foot clinic, the
informative value of re-testing people with a history of foot
ulceration is questionable. The prognostic utility of a history
of foot ulceration, an inability to feel the 10 g monofilament
and at least one absent pedal pulse indicates that the
implementation of such a simplified approach to annual
diabetes foot checks could reduce the amount of clinical time
spent testing and thereby permit more people with diabetes
to be classified for risk of foot ulceration and potentially lead
to more effective prevention.
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